---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-204982"
form_type: "8-K"
ticker: "MD"
cik: "0000893949"
company_name: "Pediatrix Medical Group, Inc."
filed_at: "2026-05-05T23:59:59+00:00"
generated_at: "2026-05-14T23:43:17.741472+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Pediatrix Q1 GAAP EPS $0.36, Adj. EPS $0.44; revenue $476M, beat expectations

## Summary
- Net revenue $476.2M, up 4% YoY from $458.4M; same-unit revenue grew 2.8%.
- Adjusted EBITDA $58.2M vs $49.2M YoY; net income $29.6M ($0.36 diluted) vs $20.7M ($0.24).
- Same-unit volume down 1.6% (hospital services -1.5%, office -3.3%) but reimbursement up 4.4%.
- Reaffirmed FY2026 Adjusted EBITDA guidance range of $280M-$300M.
- Used $21.5M for share repurchases and $7.0M for acquisitions in Q1.

## SEC filing metadata
- accession: 0001193125-26-204982
- form_type: 8-K
- ticker: MD
- cik: 0000893949
- company_name: Pediatrix Medical Group, Inc.
- filed_at: 2026-05-05T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/893949/000119312526204982/0001193125-26-204982-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/893949/000119312526204982/md-20260505.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-204982
- JSON: https://secwatch.observer/filing/0001193125-26-204982.json
- Plain text: https://secwatch.observer/filing/0001193125-26-204982.txt

## Key facts
- Earnings Releases
  Pediatrix Medical Group, Inc. reported three months ended March 31, 2026 results: revenue $476 million, net income $30 million, EPS $0.36 per share. Guidance reaffirmed.
  - Period: three months ended March 31, 2026
  - Revenue: $476 million
  - Net income: $30 million
  - EPS: $0.36 per share
  - Guidance: reaffirmed
  - Result: reported results
  source text: ended March 31, 2026. On a non-GAAP basis, Pediatrix reported Adjusted EPS of $0.44. For the 2026 first quarter, Pediatrix reported the following results: • Net revenue of $476 million; • Net income of $30 million; and • Adjusted EBITDA of $58 million. “Our first quarter operating results exceeded our expectations, driven by top-line growth,” said Mark S.
  evidence_url: https://www.sec.gov/Archives/edgar/data/893949/000119312526204982/0001193125-26-204982-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.